batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Cellectar makes its radiopharma pitch 8 January 2024 ASCO-GI preview: notable late-breakers 5 January 2024 Lacutamab lift boosts Innate 4 January 2024 First 2024 deals pick up where 2023 left off 2 January 2024 Sanofi switches to another CEACAM5 asset 21 December 2023 GSK goes back to Hansoh 20 December 2023 Compugen’s novel cytokine approach gets Gilead buy-in 19 December 2023 No overall survival not a problem for Welireg 15 December 2023 Load More